Tryp Therapeutics Inc (TRYP) Corporate Media Kit

Accelerated Time to Market Tryp Therapeutics is focused on three strategic initiatives to quickly advance its novel drug programs: Collaborate: Partner with leading academic institutions that have indication-specific expertise to conduct Phase 2a clinical trials. Develop: Shorten the timelines and lower the cost of its development programs through utilization of the FDA’s 505(b)(2) regulatory pathway with available third-party preclinical data. Protect: Safeguard the commercial lifespan of its drug candidates through patents, trade secrets, regulatory exclusivity and proprietary know-how.